课题基金 / 基金详情

ANTITUMOR ANTIBIOTICS--CC-1065 AND THE DUOCARMYCINS

ANTITUMOR ANTIBIOTICS--CC-1065 AND THE DUOCARMYCINS
抗肿瘤抗生素——CC-1065 和多卡霉素
批准号:
2601182
负责人:
DALE L BOGER
金额:
$30.26万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-02-01 至 2002-04-30

项目摘要

项目成果

DALE L BOGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Principal Investigator's) A detailed study of CC-1065 and the duocarmycins, exceptionally potent antitumor antibiotics, are described. CC-1065 and the duocarmycins derive their biological properties through a sequence selective alkylation of duplex DNA which proceeds by reversible, stereoelectronically-controlled adenine N3 addition to the least substituted carbon of the activated cyclopropane within minor groove 5 or 3.5 base pair AT-rich sites, respectively. Further studies to define the characteristics of the alkylation reaction, to determine the origin of the DNA alkylation selectivity and the source of catalysis, and to define fundamental principles underlying the relationships between structure, chemical or functional reactivity, DNA alkylation properties, and biological activity are detailed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulating Signaling Endocannabinoids and Fatty Acid Amides
  • 批准号:
    10532252
  • 项目类别:
  • 资助金额:
    $39.94万
  • 财政年份:
    2021
  • 负责人:
    DALE L BOGER
  • 依托单位:
Modulating Signaling Endocannabinoids and Fatty Acid Amides
  • 批准号:
    10399712
  • 项目类别:
  • 资助金额:
    $39.94万
  • 财政年份:
    2021
  • 负责人:
    DALE L BOGER
  • 依托单位:
A Unique Class of Reductively Activated Oncology Drugs
  • 批准号:
    9311686
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2017
  • 负责人:
    DALE L BOGER
  • 依托单位:
A Unique Class of Reductively Activated Oncology Drugs
  • 批准号:
    10116967
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2017
  • 负责人:
    DALE L BOGER
  • 依托单位:
海外基金